China-based Jiangsu Trausim Medical Instrument Co., Ltd, a wholly-owned subsidiary of Fulong Holdings and focused on dental implants and surgical instruments, has reportedly raised close to RMB 100 million (USD 13.8 million) in a Series A financing round. The round was led by Sunho Capital and MF Capital, with participation from Changzhou Ruiqi and four other medical funds. The proceeds will be used to expand core product manufacturing capacity, develop new products, file product regulatory applications, build the brand, and enhance marketing service team capabilities.
Company Profile and Intellectual Property
Founded in 2010, Trausim has established a strong intellectual property portfolio, including 7 invention patents, 31 utility model patents, and 47 authorized patents. The company has optimized and upgraded its production line at its headquarters, ensuring quality assurance with a stable manufacturing process and a robust global supply chain. This strategic investment will support Trausim’s ongoing efforts to innovate and expand its market presence in the dental and surgical instrument sectors.-Fineline Info & Tech
